Atlas Trials

Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial

Clinical trial NCT02646826 · COMPLETED

Trial details

NCT number
NCT02646826
Sponsor
Wellesley Pharmaceuticals, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nocturia
Start date
2016-01-01
Primary completion
2017-10-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.